Toxoplasma gondii: Flat-mounting of retina as a new tool for the observation of ocular infection in mice

Experimental Parasitology

Volumn 126, Issue 2, 2010, Pages 259-262

  Escoffier, P ^a,b   Jeanny, J C ^c   Marinach Patrice, C ^a,b   Jonet, L ^c   Raoul, W ^c   Behar Cohen, F ^c,d   Paris, L ^e   Danis, M ^a,b,e   Dubremetz, J F ^f   Mazier, D ^a,b,e  

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CENTRE DE RECHERCHE DES CORDELIERS   (France)

^d HÔTEL DIEU   (France)

^e PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^f UNIVERSITÉ DE MONTPELLIER   (France)

Author keywords

Flat mount of retina; Macroscopic visualization; Ocular infection; Toxoplasma gondii

Indexed keywords

BETA GALACTOSIDASE;

ACCURACY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CYST; CONTROLLED STUDY; ESCHERICHIA COLI; FEMALE; FLAT MOUNTING TECHNIQUE; FROZEN SECTION; INTERMETHOD COMPARISON; MICROSCOPY; MOUSE; NONHUMAN; PARASITE IDENTIFICATION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; FROZEN SECTIONS; MICE; RETINA; TOXOPLASMA; TOXOPLASMOSIS, OCULAR;

ANIMALIA; ESCHERICHIA COLI; MUS; TOXOPLASMA GONDII;

EID: 77955268879     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.04.006     Document Type: Article

References (18)

1. Charles E., Callegan M.C., Blader I.J. The SAG1 Toxoplasma gondii surface protein is not required for acute ocular toxoplasmosis in mice. Infection and Immunity 2007, 75:2079-2083.
2. Chipps T.J., Streeter P.R., Franc D.T., Neumeyer K., Planck S.R., Rosenbaum J.T., Smith J.R. Modification of the Woodruff-Stamper assay demonstrates binding of Toxoplasma gondii tachyzoites to retinal vascular endothelium. Journal of Immunological Methods 2006, 312:209-213.
3. Colbert S.H., Mack A.F., Fernald R.D. A novel, rapid flat-mounting technique for visualizing antibody labeling in the retina. Journal of Neuroscience Methods 1995, 62:179-183.
4. Courret N., Darche S., Sonigo P., Milon G., Buzoni-Gatel D., Tardieux I. CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood 2006, 107:309-316.
5. Da Gama L.M., Ribeiro-Gomes F.L., Guimaraes U., Arnholdt A.C. Reduction in adhesiveness to extracellular matrix components, modulation of adhesion molecules and in vivo migration of murine macrophages infected with Toxoplasma gondii. Microbes and Infection 2004, 6:1287-1296.
6. Dao A., Soete M., Sergent V., Deslee D., Fortier B., Dubremetz J.F. Potential of β-galactosidase-expressing Toxoplasma gondii for in situ localization and observation of rare stages of the parasite life cycle. Parasitology Research 2002, 88:69-72.
7. Di Cristina M., Marocco D., Galizi R., Proietti C., Spaccapelo R., Crisanti A. Temporal and spatial distribution of Toxoplasma gondii differentiation into Bradyzoites and tissue cyst formation in vivo. Infection and Immunity 2008, 76:3491-3501.
8. Garweg J.G., Candolfi E. Immunopathology in ocular toxoplasmosis: facts and clues. Memorias do Instituto Oswaldo Cruz 2009, 104:211-220.
9. Gil C.D., Mineo J.R., Smith R.L., Oliani S.M. Mast cells in the eyes of Calomys callosus (Rodentia: Cricetidae) infected by Toxoplasma gondii. Parasitology Research 2002, 88:557-562.
10. Gilbert R.E., Dunn D.T., Lightman S., Murray P.I., Pavesio C.E., Gormley P.D., Masters J., Parker S.P., Stanford M.R. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiology and Infection 1999, 123:283-289.
11. Gormley P.D., Pavesio C.E., Luthert P., Lightman S. Retinochoroiditis is induced by oral administration of Toxoplasma gondii cysts in the hamster model. Experimental Eye Research 1999, 68:657-661.
12. Grigg M.E., Ganatra J., Boothroyd J.C., Margolis T.P. Unusual abundance of atypical strains associated with human ocular toxoplasmosis. Journal of Infectious Diseases 2001, 184:633-639.
13. Holland G.N. Ocular toxoplasmosis: a global reassessment Part I: epidemiology and course of disease. American Journal of Ophthalmology 2003, 136:973-988.
14. Holland G.N. Ocular toxoplasmosis: a global reassessment Part II: disease manifestations and management. American Journal of Ophthalmololgy 2004, 137:1-17.
15. Lahmar I., Guinard M., Sauer A., Marcellin L., Abdelrahman T., Roux M., Mousli M., Moussa A., Babba H., Pfaff A.W., Candolfi E. Murine neonatal infection provides an efficient model for congenital ocular toxoplasmosis. Experimental Parasitology 2009, 124:190-196.
16. Lu F., Huang S., Kasper L.H. CD4+ T cells in the pathogenesis of murine ocular toxoplasmosis. Infection and Immunity 2004, 72:4966-4972.
17. Norose K., Mun H.S., Aosai F., Chen M., Piao L.X., Kobayashi M., Iwakura Y., Yano A. IFN-gamma-regulated Toxoplasma gondii distribution and load in the murine eye. Investigative Ophthalmology and Visual Science 2003, 44:4375-4381.
18. Pavesio C.E., Chiappino M.L., Gormley P., Setzer P.Y., Nichols B.A. Acquired retinochoroiditis in hamsters inoculated with ME 49 strain Toxoplasma. Investigative Ophthalmology and Visual Science 1995, 36:2166-2175.